ATC/DDD code V03AF for Detoxifying agents for antineoplastic treatment
Mesna in i.v. formulations used for the prophylaxis of urothelial toxicity are classified in this group. Mesna used as a mucolytic agent
(e.g. administered by a nebuliser) is classified in R05CB.
Rasburicase is classified here, other agents (e.g. febuxostat) for treatment of hyperuricaemia, see M04AA.
Glutathione is classified in V03AB - Antidotes.
The DDDs for calcium folinate, calcium levofolinate, sodium folinate and sodium levofolinate are based on the combined treatment with high doses of methotrexate.
The DDD for amifostine is based on the use as an adjunct in antineoplastic therapy.
